4 reports of this reaction
1.5% of all AMMONIA N 13 reports
#15 most reported adverse reaction
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES is the #15 most commonly reported adverse reaction for AMMONIA N 13, manufactured by 3D Imaging Drug Design and Development LLC. There are 4 FDA adverse event reports linking AMMONIA N 13 to LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES. This represents approximately 1.5% of all 259 adverse event reports for this drug.
Patients taking AMMONIA N 13 who experience loss of personal independence in daily activities should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES is a less commonly reported adverse event for AMMONIA N 13, but still significant enough to appear in the safety profile.
In addition to loss of personal independence in daily activities, the following adverse reactions have been reported for AMMONIA N 13:
The following drugs have also been linked to loss of personal independence in daily activities in FDA adverse event reports:
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES has been reported as an adverse event in 4 FDA reports for AMMONIA N 13. This does not prove causation, but indicates an association observed in post-market surveillance data.
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES accounts for approximately 1.5% of all adverse event reports for AMMONIA N 13, making it a notable side effect.
If you experience loss of personal independence in daily activities while taking AMMONIA N 13, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.